共 50 条
- [23] Radioiodine (131I) treatment decision-making for low- and intermediate-risk differentiated thyroid cancer ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2023, 67 (02): : 197 - 205
- [24] LOW-DOSE AND HIGH-DOSE RADIOIODINE IN THYROID CANCER - REPLY AMERICAN JOURNAL OF MEDICINE, 1977, 63 (01): : 167 - 168
- [25] Is radioiodine therapy always useful in patients without residual thyroid tissue after total thyroidectomy for differentiated thyroid cancer (DTC)? EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1005 - 1005
- [26] Postsurgical radioiodine ablation in low-risk differentiated thyroid cancer LANCET DIABETES & ENDOCRINOLOGY, 2022, 10 (06): : 379 - 381
- [28] Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (18): : 1663 - 1673
- [29] Surgical Treatment of Low- and Intermediate-Risk Papillary Thyroid Cancer with Minimally Invasive Video-Assisted Thyroidectomy JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (05): : 1618 - 1622
- [30] Low vs. High Radioiodine Activity to Ablate the Thyroid after Thyroidectomy for Cancer: A Randomized Study PLOS ONE, 2008, 3 (04):